Us Bancorp \De\ Iovance Biotherapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 19,655 shares of IOVA stock, worth $159,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,655

Previous 28,458 30.93%

Holding current value

$159,991

Previous $228,000 19.3%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$7.28 - $11.9 $64,085 - $104,755	-8,803 Reduced 30.93%	19,655 $184,000
Q2 2024 Aug 06, 2024	SELL	$7.78 - $14.19 $24,110 - $43,974	-3,099 Reduced 9.82%	28,458 $228,000
Q1 2024 May 07, 2024	BUY	$7.59 - $17.47 $127,512 - $293,496	16,800 Added 113.84%	31,557 $467,000
Q4 2023 Feb 09, 2024	BUY	$3.3 - $8.89 $33,561 - $90,411	10,170 Added 221.71%	14,757 $119,000
Q3 2023 Nov 03, 2023	SELL	$4.44 - $8.79 $4,040 - $7,998	-910 Reduced 16.55%	4,587 $20,000
Q2 2023 Aug 09, 2023	SELL	$5.36 - $9.06 $503 - $851	-94 Reduced 1.68%	5,497 $38,000
Q1 2023 May 09, 2023	BUY	$5.53 - $8.22 $13,017 - $19,349	2,354 Added 72.72%	5,591 $34,000
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $4,102 - $7,300	730 Added 29.12%	3,237 $20,000
Q3 2022 Oct 27, 2022	SELL	$9.53 - $13.11 $14,218 - $19,560	-1,492 Reduced 37.31%	2,507 $24,000
Q2 2022 Aug 01, 2022	BUY	$6.38 - $18.33 $4,631 - $13,307	726 Added 22.18%	3,999 $44,000
Q1 2022 May 11, 2022	SELL	$12.38 - $19.1 $12,813 - $19,768	-1,035 Reduced 24.03%	3,273 $54,000
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $69,195 - $115,521	-4,181 Reduced 49.25%	4,308 $82,000
Q3 2021 Nov 10, 2021	BUY	$20.35 - $26.63 $56,308 - $73,685	2,767 Added 48.36%	8,489 $209,000
Q2 2021 Aug 05, 2021	BUY	$16.33 - $33.07 $23,025 - $46,628	1,410 Added 32.7%	5,722 $150,000
Q1 2021 Apr 28, 2021	SELL	$28.67 - $52.59 $471,936 - $865,683	-16,461 Reduced 79.24%	4,312 $136,000
Q4 2020 Feb 04, 2021	BUY	$28.04 - $50.26 $225,021 - $403,336	8,025 Added 62.95%	20,773 $964,000
Q3 2020 Nov 10, 2020	BUY	$27.75 - $36.3 $254,134 - $332,435	9,158 Added 255.1%	12,748 $420,000
Q2 2020 Aug 07, 2020	SELL	$27.21 - $41.0 $2,666 - $4,018	-98 Reduced 2.66%	3,590 $99,000
Q1 2020 May 13, 2020	BUY	$19.54 - $38.85 $30,814 - $61,266	1,577 Added 74.7%	3,688 $110,000
Q4 2019 Feb 04, 2020	BUY	$17.95 - $29.41 $15,903 - $26,057	886 Added 72.33%	2,111 $58,000
Q3 2019 Nov 08, 2019	BUY	$17.99 - $26.0 $5,289 - $7,644	294 Added 31.58%	1,225 $23,000
Q2 2019 Aug 13, 2019	BUY	$9.78 - $24.52 $9,105 - $22,828	931 New	931 $23,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account